NMR-based biosensors that utilize laser-polarized xenon offer potential advantages beyond current sensing technologies. These advantages include the capacity to simultaneously detect multiple analytes, the applicability to in vivo spectroscopy and imaging, and the possibility of "remote" amplified detection. Here we present a detailed NMR characterization of the binding of a biotin-derivatized caged-xenon sensor to avidin. Binding of "functionalized" xenon to avidin leads to a change in the chemical shift of the encapsulated xenon in addition to a broadening of the resonance, both of which serve as NMR markers of ligand-target interaction. A control experiment in which the biotin-binding site of avidin was blocked with native biotin showed no such spectral changes, confirming that only specific binding, rather than nonspecific contact, between avidin and functionalized xenon leads to the effects on the xenon NMR spectrum. The exchange rate of xenon (between solution and cage) and the xenon spin-lattice relaxation rate were not changed significantly upon binding. We describe two methods for enhancing the signal from functionalized xenon by exploiting the laser-polarized xenon magnetization reservoir. We also show that the xenon chemical shifts are distinct for xenon encapsulated in different diastereomeric cage molecules. This demonstrates the potential for tuning the encapsulated xenon chemical shift, which is a key requirement for being able to multiplex the biosensor.
Introduction
Developments of new approaches in analytical chemistry are being increasingly driven by advances and applications of combinatorial chemistry and parallel assays. Products of combinatorial syntheses require fast and sensitive screening techniques due to the production of large numbers of chemical analogues to be tested for affinity, catalytic activity, or other properties of interest. [1] [2] [3] Various detection methodologies for high-throughput screening (HTS) applications, including laser-induced fluorescence, fluorescence polarization, and fluorescence energy transfer, have been implemented in high density microtiter plate format. [4] [5] [6] [7] The spatial separation of possible interacting pairs distinguishes signals from 3 different ligand-target combinations, and readings are made by scanning techniques or by imaging. 8 At present, particular challenges exist in the development of multiplexed assays, which allow multiple interactions in samples to be detected simultaneously.
Macromolecule-based biosensors exploit the specificity and strength of biological ligand-target interactions to selectively signal the presence of particular molecular targets. These biosensors rely on the coupling of biological recognition events to an experimental observable, allowing external detection.
Historically, biosensors have been used for routine analyses in clinical diagnosis, as in the case of the traditional glucose sensor; 9 however, new concepts in biosensor design are being considered for highthroughput applications such as drug discovery. 10 Recent developments in biosensor technology, such as surface plasmon resonance chips, 11 are already being developed in a multiplexed format. 12 Nuclear magnetic resonance (NMR) is powerful in analytical chemistry applications due to its high information content. Steady progress is being made to incorporate NMR analysis into high-throughput and combinatorial chemistry applications. [13] [14] [15] [16] [17] [18] Utilization of conventional NMR for high-throughput biosensor applications may be limited by the intrinsically low sensitivity and the complexity of spectra obtained from biomolecules and mixtures. Laser-polarization 19 of 129 Xe offers an increase in signal-tonoise by several orders of magnitude relative to the equilibrium nuclear-spin polarizations measured in normal NMR experiments. 20, 21 In addition, 129 Xe NMR spectra are less complex than those from 1 H or 13 C NMR, usually showing only a few, easily interpretable lines with no background signal. Despite its spectral simplicity, xenon exhibits the important property that it can sensitively report on its local environment via its chemical shift and relaxation parameters. Furthermore, xenon NMR and MRI can take advantage of "remote" detection of signals that can be used to reconstruct substantially amplified spectra 22 and images. 23 NMR of 129 Xe has been used to investigate the structure and dynamics of materials, [24] [25] [26] [27] molecular cages, [28] [29] [30] [31] [32] [33] [34] biological systems, and for biomedical applications. [35] [36] [37] Recently, extensive reviews regarding the history and development of hyperpolarized xenon NMR have been published. 38, 39 4
Biological systems studied with 129 Xe NMR include globular proteins such as myoglobin and hemoglobin, [40] [41] [42] [43] [44] [45] [46] membrane associated peptides such as gramicidin, 47 and lipid membranes themselves. 48 While xenon shows appreciable binding to many proteins, as evidenced by its use in making heavy atom derivatives of protein crystals for x-ray crystallography, 49 In spite of the favorable attributes of xenon interacting with proteins in solution, high-sensitivity molecular sensing is not compatible with the fast-exchange characteristic of xenon-protein interactions.
This limitation can be overcome by increasing the strength of a particular xenon interaction that reports analyte binding allowing a resonance to be resolved from those averaged into the single fast-exchange peak. To realize this, we have taken the approach of 'functionalizing' the xenon by providing a physical coupling between xenon and the ligand that targets a protein. Recently, as a proof-of-principle case, we reported a molecule designed to be an NMR biosensor that targeted the biotin-binding protein avidin. 51 The sensor consists of a modified cryptophane-A cage, to which xenon binds as the NMR reporter, connected via a tether to the ligand biotin ( Figure 1) . The Xe NMR signal demonstrated a response to Implementation of high-sensitivity fluorescence-based systems in a direct multiplexing assay is challenging due to spectral overlap, despite the high wavelength tunability of some systems such as quantum-dot-tagged microbeads. 52, 53 In microarray format, realization of the xenon biosensor could result in a high density assay in which each well of the microtiter plate would not contain individual interacting pairs, but rather a single synthetic product interacting with a complete set of derivatized target molecules. Within each well, binding to different targets would be distinguishable on the basis of chemical shift.
In this work, we provide a detailed characterization of this avidin binding, functionalized-xenon system. The high sensitivity of the functionalized xenon to its environment is demonstrated by the observation that different diastereomer products of the cryptophane synthesis yield different chemical 6 shifts. Upon the addition of protein, additional resonances appear in the spectrum that can be attributed to protein-bound functionalized xenon. An increase in the functionalized-xenon resonance linewidth is apparent in the spectrum upon binding to the protein. The exchange rates of both protein-bound and free functionalized xenon were measured to investigate the origin of broadening in the protein-bound functionalized-xenon resonance. Finally, two methods for signal-to-noise amplification by selective excitation of bound xenon are also presented. Implications of these studies for the application of the functionalized-xenon biosensors in the ordinary and multiplexing capacity are discussed. and IBURP2 pulses 54 were generated using the PBox program (Varian Instruments). Both selective pulses are designed to excite a bandwidth of 1.8 kHz centered at 10.25 kHz upfield of the frequency of xenon in water, corresponding to a ~21.8 ppm excitation window centered about the NMR frequency of xenon bound to water-soluble cryptophanes. Natural-abundance xenon (Isotec or Spectra Gases) was laser-polarized using a commercial polarizer (Amersham Health, Durham, NC) and introduced to the sample using previously described methods, 42 with polarizations of 1-5%. In order to remove molecular oxygen, samples were degassed via several freeze-pump-thaw cycles prior to the introduction of xenon. Hz for intensities integrated in Figure 6 . Ninety-degree pulses were used for acquiring spectra unless otherwise noted. Exchange signal-averaging was used for the spectra shown in Figures 4c through 4e (n = 10) and also for Figure 6 (n ≥ 3). Specific pulse sequences for exchange measurement and exchange signal-averaging techniques are presented in the corresponding figures. For both the exchange signalaveraging and indirect-assay experiments, τ mix was at least 150 ms. Concentrations of particular biosensor samples are noted where relevant and were determined before addition of protein by UV-VIS spectrophotometry using a molar absorptivity for water-soluble cryptophanes (ε 287 = 8000 M -1 ), as determined by the dry weight method. The molar absorptivity for cryptophane in aqueous solution was found to be different than that previously used for cryptophane in organic solution.
Materials and Methods

NMR experiments
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Synthetic Strategy
Preparation of the cryptophane-acetic acid cage (1, Figure 2 ), which is the precursor to the biosensor molecule, was based on the template method previously reported by Collet and co-workers. 55 A key feature in the preparation of such derivatized cryptophanes is the substitution of one of the methyl ether groups for a suitable reactive moiety such as 2-acetic acid. As shown in Figure 2 , we envisioned this substitution in the final product to originate from the derivatization of a 3,4-dihydroxybenzaldehyde precursor at the meta position. Our initial effort with R = methyl 2-acetate was unproductive due to side reactions in the final cyclization step. We thus opted to substitute this position with a protecting group, and mindful of the stereoelectronic impact of protecting groups on the cyclization efficiency 55 we selected an allyl group. This protecting group is indeed known to give good cyclization yield, 55, 56 and the direct elaboration of the allyl functionality via oxidation offers alternatives to a deprotectionalkylation sequence. We thus needed access to 5 where R is an allyl group. Selective meta-allylation of 3,4-dihydroxybenzaldehyde has been reported using 2 equivalents of sodium hydride to generate the bisphenoxide anion prior to allyl bromide addition. 57 It is important to note that the monodeprotonated 3,4-dihydroxybenzaldehyde exhibits excellent selectivity for para-alkylation by virtue of the lower acidity of the conjugate para-phenol. Incomplete deprotonation leads to compromised selectivity.
Scheme 1 shows a practical alternative for the preparation of 3-allyloxy-4-hydroxy benzaldehyde (7) that Scheme 1. a. involves first the allylation of both hydroxyl groups of the 3,4-dihydroxybenzaldehyde (6) followed by the selective deprotection at the para position by palladium mediated allyl-transfer. It is speculated that the selectivity in the deprotection stems from the kinetically favored π-allyl insertion into the more acidic phenolic position. Subsequent para derivatization with 1,2-dibromoethane and reduction were carried out according to previously reported procedures to obtain 8 in good yield. 
11
with substoichiometric amounts of reagents to obtain the desired monoprotected 10 as well as the bisprotected and fully deprotected material. The undesired materials were recycled by resubjection to the deprotection conditions or reintroduction of an allyl group. Two units of 4 were then introduced under standard alkylation conditions to afford 11. The remaining allyl protecting group on cyclotriveratrylene template 11 was removed to afford phenol 12, which was alkylated with 13 to afford the cyclization precursor 14. The templated cyclization of 14 proceeded smoothly according to the previously reported conditions 55 to provide cryptophane 15 in 55-60% yield. Direct conversion of the allyl group to the carboxylic acid using catalytic amounts of RuCl 3 and NaIO 4 afforded a complex mixture of products. Instead, the desired 2-cryptophaneacetic acid 1 was obtained by the removal of the allyl group and the resulting phenol was alkylated with methyl 2-bromoacetate followed by LiOH saponification.
A highly charged 3-amino-acid peptide (16, Scheme 3) was attached to (1) at the acetic acid site, to 
Synthetic details
The 3,4-dihydroxybenzaldehyde 6 (5.00 g, 36.2 mmol, 1.0 equiv) was dissolved in anhydrous DMF at room temperature and treated with K 2 CO 3 (12.5 g, 90.6 mmol, 2.5 equiv). Allyl bromide (9.63 g, 79.7 mmol, 2.2 equiv) was then added and the reaction was warmed to 80 °C. After 2 hours, TLC analysis revealed complete conversion of the starting material to the desired bisallylated product. The reaction mixture was poured into a 1:1 mixture of Et 2 O:EtOAc (150 mL), washed with 1 M HCl (2 x 100 mL) and brine (100 mL). The organic layer was dried over MgSO 4 and concentrated in vacuo. The crude oil was purified by flash chromatography on silica gel using a 10% to 40% gradient of EtOAc in hexane to recover 7.27 g of colorless oil which slowly crystallized over several days (92% yield).
The 3,4-diallyoxybenzaldehyde (7.27 g, 33.3 mmol, 1.0 equiv) was dissolved in CH 2 Cl 2 (100 mL) and treated with Pd(PPh 3 ) 4 (0.985 g, 0.833 mmol, 0.025 equiv) at room temperature followed by drop-wise 13 addition of n-Bu 3 SnH (9.60 g, 33.3 mmol, 1.0 equiv). The reaction was allowed to proceed for 30 min after which TLC analysis indicated ca. 20% remaining starting material. Additional n-Bu 3 SnH (3.84 g, 8.32 mmol, 0.25 equiv) was added to drive the reaction to completion. The reaction mixture was concentrated in vacuo and purified by flash chromatography on silica gel, eluting first with 10% EtOAc in hexane, followed by a gradient from 20% to 50% of EtOAc in hexane to recover 4.34 g of 7 as colorless oil which slowly crystallized over time (82% yield).
Mono-protected phenol 7 (4.34 g, 24.6 mmol, 1.0 equiv) in DMF (50 mL) at 80 °C was treated with K 2 CO 3 (4.10 g, 29.5 mmol, 1.2 equiv) followed by 1,2-dibromoethane (18.4 g, 98.4 mmol, 4.0 equiv).
The reaction was allowed to proceed for 8 h after which it was diluted with Et 2 O (300 mL) and washed with 1 M HCl (3 x 100 mL). The organic phase was dried over MgSO 4 , concentrated in vacuo and purified by flash chromatography on silica gel, eluting with a gradient from 20% to 50% of EtOAc in hexane to recover 5.37 g (76% yield). This material (18.7 mmol) was dissolved in THF (50 mL), cooled to 0 °C and reacted with NaBH 4 (1.09 g, 18.7 mmol, 1.0 equiv) followed by MeOH (4.7 mL, 187 mmol, 14 The mono protected cyclotriveratrylene 10 (700 mg, 1.56 mmol, 1.0 equiv) was dissolved in DMF (10 mL) and treated with K 2 CO 3 (540 mg, 3.89 mmol, 2.5 equiv) followed by the addition of bromide 4
(1.34 g 3.89 mmol, 2.5 equiv) and tetrabutylamonium iodide (60 mg, 0.156g, 0.1 equiv). The reaction was stirred for 8 h at 80 °C after which it was diluted with EtOAc (100 mL) and washed with brine (3 x 100 mL). The crude product was purified by flash chromatography (50% EtOAc in hexanes) to recover 1.22 g of compound 11.
Compound 11 (1.1 g, 1.12 mmol, 1.0 equiv) was dissolved in CH 2 Cl 2 (5 mL) at 23 °C, and Pd(PPh 3 ) 4 (0.129 g, 0.112 mmol, 0.1 equiv) was added followed by tributyltin hydride (0.492 g, 1.68 mmol, 1.5 equiv). After 3 hrs, the reaction was concentrated onto silica and loaded directly onto a short column.
An elution of 1:9 EtOAc:hexanes was used until all the tin byproducts were removed, then with 3:1 EtOAc:hexanes elution was used to recover 0.934 g of phenol 12.
Phenol 12 (480 mg, 0.512 mmol, 1.0 equiv) in DMF (10 mL) was treated with K 2 CO 3 (107 mg, 0.768 mmol, 1.5 equiv) followed by bromide 8 (0.173 g 0.614 mmol, 1.2 equiv) and tetrabutylamonium iodide. The reaction was stirred for 8 h at 80 °C after which it was diluted with EtOAc (100 mL) and washed with brine (3 x 100 mL). The crude product was purified by flash chromatography (50% EtOAc in hexanes) to recover 0.491 g of compound 14.
Compound 14 (400 mg, 0.350 mmol) was dissolved in chloroform (6 mL) and formic acid (500 mL) was added. The reaction was heated to 55 °C for 2.5 hr, concentrated and chromatographed using a gradient from 0 to 15% of acetone in CH 2 Cl 2 to recover 187 mg of pure cryptophane 15. 
Results and Discussion
Biosensor Molecule Diastereomers Detected by Functionalized Xenon
The spectrum of xenon in a solution of the biotin-derivatized cryptophane (Figure 1 ), in the absence of protein, contains four peaks near ~70 ppm (Figure 3c ) from xenon inside the cryptophane(s) and a large peak at ~195 ppm that corresponds to xenon dissolved in water (not shown). We attribute the four functionalized-xenon peaks to distinct xenon chemical shifts arising from the diastereomers of the biosensor molecule.
Cryptophane-A is chiral, 55 and xenon dissolved in a racemic mixture of the cage enantiomers gives rise to a single resonance. 31 Similarly, the xenon spectrum for a racemic mixture of the allyl-substituted cryptophane-A cage enantiomers (15) shows only one resonance (Figure 3a) . However, the spectra of the xenon biosensor exhibit multiple peaks rather than a single resonance (Figure 3c ). This is a consequence of the formation of diastereomer biosensor molecules resulting from the addition of new chiral centers to the cage precursor (15) . The first pair of diastereoisomers is formed by the introduction 
60-63
Previous experimental studies, which are now being understood with theoretical models by Sears and Jameson, 64 have shown that direct changes to the basic structure of the cryptophane-A cage perturb the chemical shift of the cryptophane-encapsulated xenon. For example, a 30 ppm change in chemical shift was noted when the length of the bridges between the cyclotriveratrylene caps of cryptophane-A was increased by one methylene group, 51 and even deuteration of a single methoxy group on a cryptophane-A cage has been shown to produce a noticeable shift (~0.1 ppm). 65 In this work, we show that significant xenon chemical shift differences also result from derivatizations of cryptophane-A that are not local to the encapsulated xenon. Namely, the presence of chiral centers attached to the outside of the cage cause changes of up to ~1 ppm in the xenon chemical shift. The sensitivity of xenon to indirect changes in cage structure or environment is important for distinguishing bound and free ligand in addition to offering greater potential for multiplexing the xenon biosensor. By combining different 18 chemical changes in and around the cryptophane it will be possible to tune the chemical shift of the xenon in the cage, making it possible to follow binding events of different ligand-cage combinations in parallel.
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Characteristics of Protein-Bound Functionalized Xenon Spectrum
Titration of Biotinylated Functionalized-Xenon Biosensor with Avidin Protein
We previously showed that the chemical shift of the biotinylated cryptophane-A biosensor is sensitive to the presence of avidin. 51 We have now extended the experiments to a complete titration of the free biosensor with avidin ( Figure 4) showing that increasing amounts of avidin lead to corresponding 
Verification of Correspondence between Spectral Changes and Binding Event
When the biotinylated xenon biosensor (300 µM) is added to avidin (180 µM) that had been preequilibrated with a five-fold excess of normal biotin, the xenon spectrum is unchanged compared to that of the same concentration of biosensor alone ( Figure 5 ). This control experiment demonstrates that the 
Exchange Measurements
The biosensor-protein binding event may decrease the lifetime of xenon in the cage thereby making exchange linebroadening more efficient. To determine whether this was the case, the exchange rates were measured for both free and protein-bound biosensor.
The exchange of xenon between cage and solution was determined by measuring the recovery of selectively saturated functionalized-xenon signal. The pulse sequence used is shown in Figure 6a , in which all pulses are ~90° chemical-shift-selective pulses centered on the resonance frequency of functionalized xenon as described in the experimental section. The initial observation of the zmagnetization of the functionalized xenon is followed by an exchange delay, τ mix , followed by another observation of the z-magnetization. The measurement of the signal intensity following the first pulse allows for the normalization of exchange-recovered intensity observed by the second pulse (Figure 6b ).
Without exchange, recovery of magnetization would be negligible as the equilibrium magnetization is small relative to the initial magnetization achieved with laser-polarization. The growth of magnetization during τ mix occurs only through exchange with polarized xenon atoms in the solvent, allowing the rate to be determined via curve-fitting to a pseudo-first-order exchange mechanism, 66 as shown in Figure 6c . This method presumes that a single saturation of the functionalized-xenon resonance does not significantly change the polarization of the xenon free in solution and that no significant spin-lattice relaxation of free xenon occurs between the first and second saturations. These are reasonable assumptions as free xenon is present in greater than 10-fold excess, and the spin-lattice relaxation time of free xenon in these solutions is on the order of hundreds of seconds, as measured by probing the longitudinal magnetization of the free xenon using tipping angles of ~3° at regular intervals (data not shown). proteins, 68, 69 and also to cryptophane cage protons. 70, 71 Studies at different magnetic fields as well as studies with deuterated cages should help distinguish contributions from the two mechanisms.
Exchange rates comparable to those of xenon in the biosensor have been measured previously for xenon-cryptophane complexes in organic solutions at very low temperatures. 65 In organic solvents at room temperature, cryptophane-A-bound xenon shows exchanged-broadened linewidths of hundreds of Hertz, 31 suggesting exchange rates more than an order of magnitude higher than those measured here.
The slower exchange reflected in the narrower lines of the water-soluble xenon-cryptophane-A complex presented here suggest a higher binding constant of xenon in water than organic solvents, consistent with a larger hydrophobic contribution to the binding.
Methods for Enhancing Biosensor Sensitivity
In conventional-NMR signal averaging, individual scans are comprised of excitation, followed by acquisition and signal-recovery periods in which the magnetization is allowed to return toward thermal equilibrium. Experiments involving laser-polarized xenon are not amenable to this type of signal averaging because the large initial magnetization is non-equilibrium. Following the first acquisition, the xenon would relax back to its small, equilibrium polarization and subsequent scans would add negligible signal to the initial contribution of hyperpolarized xenon signal. Reestablishing the polarization requires adding more laser-polarized xenon to the sample, a substantial cost in experiment time.
Modified pulse sequences are often employed in laser-polarized xenon NMR spectroscopy and imaging to maximize use of the xenon magnetization. 72, 73 The exchange properties of the biosensor system presented here allow for the implementation of novel signal enhancement techniques using 
Exchange Signal-Averaging
Identification of a protein binding event by observation of a shift and broadening in the spectrum only requires the spectral region including the caged-xenon resonance and not that from xenon in the solvent.
The cryptophane-bound xenon can be selectively excited using chemical-shift selective pulses. The polarization of xenon in the solvent is left to serve as a magnetization reservoir from which functionalized-xenon magnetization is replenished following an appropriate mixing time, τ mix . Repeat acquisitions of functionalized xenon spectra are added to result in a higher signal-to-noise spectrum.
However, the magnetization of the xenon in solvent is a finite reservoir, limiting the number of spectra contributing a signal-to-noise enhancement to the average. Estimates of the bulk xenon T 1 value as well as the concentrations of both biosensor molecule and dissolved xenon allow an accurate calculation of how much averaging is beneficial. Figure 7a shows the pulse sequence used to accomplish exchange- 
Indirect Assay for Biosensor Event by Xenon Exchange
In the simplest case, a xenon biosensor assay only requires relating a measurement of magnetization intensity to a quantity of protein-bound biosensor. This does not necessitate the acquisition of a functionalized xenon spectrum. Here we introduce a method, Figure 8a , that measures changes in the intensity from other factors including the initial tip pulse, T 1 relaxation, and shaped pulse error were investigated. This was done by repeating the indirect assay with an off-resonance inversion pulse. The shaped pulse, which is normally centered about the functionalized xenon spins, is placed at an equal but opposite offset from the solution resonance. By mirroring the position of the shaped pulse, inversion of the biosensor magnetization is eliminated while maintaining an identical residual excitation of free xenon in both experiments. In addition, the delay between probe pulses (n = 5; τ mix = 150 ms) is unchanged in the off-resonance experiment allowing for equal T 1 reduction in free xenon magnetization as compared to that of an on-resonance indirect assay. We found a 10% reduction in magnetization intensity after applying the off-resonance indirect assay pulse sequence, indicating the full reduction of signal intensity is associated with the presence of cryptophane-bound xenon.
The indirect assay for the xenon biosensor has sensitivity advantages over signal averaging. Its signal-to-noise ratio scales directly with the number of scans because the signal is acquired after the biosensor magnetization has accumulated. Unlike the functionalized-xenon signal, the observed solution-xenon signal not only scales with increasing laser-polarization, but also scales directly with the concentration of dissolved xenon. Hence, the limit of detection in terms of biosensor concentration is reduced. A full description of the application of this technique to quantitatively report and distinguish free and bound biosensor will be presented elsewhere.
Conclusions
The magnetic resonance properties of encapsulated xenon tethered to biotin, both free and bound to avidin, have been characterized. Detection of diastereomers by xenon has been reported for the first time and explains the presence of multiple lines observed in the functionalized xenon spectra. This suggests that the sensitivity of xenon to subtle changes in cage structure can be exploited to create sets of sensors that can be detected in parallel, thereby allowing for multiplexing at the chemical level. A full titration of the xenon biosensor with avidin is presented, showing a marked broadening of the xenon biosensor upon avidin binding. An increase in the xenon exchange rate was ruled out as a source of this broadening because the rate of xenon transfer is not significantly altered when the cage derivative binds to the protein. This rate is sufficiently slow that it does not contribute significantly to the linewidth of the protein-bound biosensor resonance. The broadening of the protein-bound functionalized xenon resonance results from an increase in the correlation time of the higher molecular weight complex through dipole-dipole and perhaps chemical shift anisotropy mechanisms. Asymmetrically hydroxylderivatized cryptophane-A cages termed cryptophanols, which were developed independently by Dutasta and co-workers, 74 may also be used for the preparation of biosensor molecules. Dutasta and coworkers have also shown that cryptophanol-A cages can be partially deuterated, 75 and use of these unique constructs in biosensor molecules should allow for experiments that distinguish the dipolar and Signal enhancement using the exchange properties of the laser-polarized xenon biosensor was demonstrated to improve detection sensitivity. The techniques presented here are applicable to any system which binds xenon such that the exchange rate is slow on the chemical shift time scale, but fast on the spin-lattice relaxation time scale; a number cage molecules in the solid state and in solution show affinity and exchange properties for xenon. [28] [29] [30] 32, 33 Exchange signal-enhancement of the xenon 29 biosensor may extend its application to environments where analyte concentration is expected to be very low, such as for in vivo spectroscopy and imaging. 76 Moreover, it offers the possibility for even higher sensitivity remote detection. 
